109
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Increased brain radioactivity by intranasal 32P-labeled siRNA dendriplexes within in situ-forming mucoadhesive gels

, , &
Pages 1373-1385 | Published online: 12 Mar 2012

References

  • LansleyABMartinGPNasal drug deliveryHilleryAMLloydAWSwarbrickJDrug Delivery and TargetingBoca Raton, FLCRC Press2001237268
  • ThorneRGEmoryCRAlaTAFreyWHIIQuantitative analysis of the olfactory pathway for drug delivery to the brainBrain Res19956922782828548316
  • FreyWHIILiuJCXThorneRGFawcettJRAlaTARahmanYEDelivery of 125I-NGF to the brain via the olfactory routeDrug Deliv199748792
  • LochheadJJThorneRGIntranasal delivery of biologics to the central nervous systemAdv Drug Deliv Rev2011Epub Nov15
  • PardridgeWMshRNA and siRNA delivery to the brainAdv Drug Deliv Rev2007592–314115217434235
  • IllumLTransport of drugs from the nasal cavity to the central nervous systemEur J Pharm Sci200011111810913748
  • IllumLIs nose-to-brain transport of drugs in man a reality?J Pharm Pharmacol20045631714979996
  • MistryAStolnikSIllumLNanoparticles for direct nose-to-brain delivery of drugsInt J Pharm200937914615719555750
  • DhuriaSVHansonLRFreyWHIIIntranasal delivery to the central nervous system: mechanisms and experimental considerationsJ Pharm Sci2010991654167319877171
  • BakerHGenterMBThe olfactory system and the nasal mucosa as portals of entry of viruses, drugs, and other exogenous agents into the brainDotyRLHandbook of Olfaction and GustationNew YorkMarcel Dekker2003549573
  • BornJLangeTKernWMcGregorGPBickelUFehmHLSniffing neuropeptide: a transnasal approach to the human brainNat Neurosci2002551451611992114
  • ErmischABarthTRühleHJSkopkováJHrbasPLandgrafROn the blood–brain barrier to peptides: accumulation of labelled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regionsEndocrinol Exp19851929373872788
  • KangYSParkJHBrain uptake and the analgesic effect of oxytocin – its usefulness as an analgesic agentArch Pharm Res20002339139510976589
  • BoudreauRLDavidsonBLRNAi therapeutics for CNS disordersBrain Res2010133811212120307511
  • UnoYPiaoWMiyataKNishinaKMizusawaHYokotaTHigh-density lipoprotein facilitates in vivo delivery of α-tocopherol-conjugated short-interfering RNA to the brainHum Gene Ther201122671171921166521
  • NakajimaHKuboTSemiYA rapid, targeted, neuron-selective, in vivo knockdown following a single intracerebroventricular injection of a novel chemically modified siRNA in the adult rat brainJ Biotechnol2012157232633322079868
  • Al-JamalKTGherardiniLBardiGFunctional motor recovery from brain ischemic insult by carbon nanotube-mediated siRNA silencingProc Natl Acad Sci U S A201110827109521095721690348
  • BonoiuACBergeyEJDingHGold nanorod–siRNA induces efficient in vivo gene silencing in the rat hippocampusNanomedicine (Lond)20116461763021718174
  • ChengDCaoNChenJYuXShuaiXMultifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in ratBiomaterials20123341170117922061491
  • StilesDZhangZGePWidespread suppression of huntingtin with convection-enhanced delivery of siRNAExp Neurol2011Epub Nov19
  • AkaneyaYJiangBTsumotoTRNAi induced gene silencing by local electroporation in targeting brain regionJ Neurophysiol20059359460215604463
  • XiaCFZhangYBoadoRJPardridgeWMIntravenous siRNA of brain cancer with receptor targeting and avidin-biotin technologyPharm Res200724122309231617926121
  • KimSSYeCKumarPTargeted delivery of siRNA to macrophages for anti-inflammatory treatmentMol Ther2010185993100120216529
  • JinJBaeKHYangHIn vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticlesBioconjug Chem201122122568257222070554
  • KuwaharaHNishinaKYoshidaKEfficient in vivo delivery of siRNA into brain capillary endothelial cells along with endogenous lipoproteinMol Ther2011122213222121915100
  • KumarPWuHMcBrideJLTransvascular delivery of small interfering RNA to the central nervous systemNature2007448394317572664
  • KimIDKimSWLeeJKGene knockdown in the olfactory bulb, amygdala, and hypothalamus by intranasal siRNA administrationKorean J Anat200942285292
  • PerezAPRomeroELMorillaMJEthylendiamine core PAMAM dendrimers/siRNA complexes as in vitro silencing agentsInt J Pharm20093801–218920019577619
  • CharltonSJonesNSDavisSSIllumLDistribution and clearance of bioadhesive formulations from the olfactory region in man: Effect of polymer type and nasal delivery deviceEur J Pharm Sci20073029530217223022
  • PerezAPCosakaMLRomeroELMorillaMJUptake and intracellular traffic of siRNA dendriplexes in glioblastoma cells and macrophagesInt J Nanomedicine201162715272822114502
  • JonesDSBruschiMLDe FreitasOGremiaoMPDLaraEHGAndrewsGPRheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavityInt J Pharm2009372495819429268
  • GratieriTGelfusoGMRochaEMSarmentoVHde FreitasOLopezRFA poloxamer/chitosan in situ forming gel with prolonged retention time for ocular deliveryEur J Pharm Biopharm20107518619320188828
  • JonesDSBrownAFWoolfsonADSolute and solvent effects on the thermorheological properties of poly(oxyethylene)-poly(oxypropylene) block copolymers: implications for pharmaceutical dosage form designJ Appl Polym Sci20038710161026
  • JonesDSBrownAFWoolfsonADRheological characterization of bioadhesive, antimicrobial, semisolids designed for the treatment of periodontal diseases: transient and dynamic viscoelastic and continuous shear analysisJ Pharm Sci2001901978199011745757
  • MalekACzubaykoFAignerAPEG grafting of polyethylenimine (PEI) exerts different effects on DNA transfection and siRNA-induced gene targeting efficacyJ Drug Target20081612413918274933
  • MartinacAFilipović-GriĉćJVoinovichDPerissuttiBFranceschinisEDevelopment and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal deliveryInt J Pharm2005291697715707733
  • JanssonBHägerströmHFransénNEdsmanKBjörkEThe influence of gellan gum on the transfer of fluorescein dextran across rat nasal epithelium in vivoEur J Pharm Biopharm200559355756415760737
  • BindseilEBechgaardEJorgensenLLarsenRMorphological examination of rabbit nasal mucosa after exposure to acetylsalicylic acid, glycofurol75 and ephedrineInt J Pharm19951193746
  • CollaudSPengQAGurnyRLangeNThermosetting gel for the delivery of 5-aminolevulinic acid esters to the cervixJ Pharm Sci2008972680269017828758
  • HartikkaJGeallABozoukovaVPhysical characterization and in vivo evaluation of poloxamer-based DNA vaccine formulationsJ Gene Med20081077078218425981
  • JeongBKimSWBaeYHThermosensitive sol–gel reversible hydrogelsAdv Drug Deliv Rev200254375111755705
  • El KamelAHIn vitro and in vivo evaluation of pluronic F127-based ocular delivery system for timolol maleateInt J Pharm2002241475512086720
  • SoaneRJFrierMPerkinsACJonesNSDavisSSIllumLEvaluation of clearance characteristics of bioadhesive systems in humansInt J Pharm199978556510205625
  • TasCOzkanCKSavaserAOzkanYTasdemirUAltunayHNasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluationEur J Pharm Biopharm20066424625416870409
  • RubinBKDruceHRamirezOEPalmerREffect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitisAm J Respir Crit Care Med1997155201820239196110
  • UgwokeMIAguRUVerbekeNKingetRNasal mucoadhesive drug delivery: background, applications, trends and future perspectivesAdv Drug Del Rev2005571116401665
  • DongZKatsumiHSakaneTYamamotoAEffects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in ratsInt J Pharm201039324425220417700
  • van de WaterFMBoermanOCWouterseACPetersJGPRusselFGMasereeuwRIntravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubulesDrug Metab Dispos2006341393139716714375
  • GaoSDagnaes-HansenFNielsenEJBThe effect of chemical modification and nanoparticle formulation on stability and biodistribution of siRNA in miceMol Ther2009171225123319401674
  • HanIn-KKimMYByunH-MEnhanced brain targeting efficiency of intranasally administered plasmid DNA: an alternative route for brain gene therapyJ Mol Med200785758317089096
  • MerkusFWvan den BergMPCan nasal drug delivery bypass the blood–brain barrier? Questioning the direct transport theoryDrugs R D2007813314417472409
  • OberdörsterGOberdörsterEOberdörsterJNanotoxicology: an emerging discipline evolving from studies of ultrafine particlesEnviron Health Perspect200511382383916002369
  • WangBFengWYWangMTransport of intranasally instilled fine Fe2O3 particles into the brain: micro-distribution, chemical states, and histopathological observationBiol Trace Elem Res200711823324317916926
  • WangJLiuYJiaoFTime-dependent translocation and potential impairment on central nervous system by intranasally instilled TiO(2) nanoparticlesToxicology2008254829018929619
  • van RooyICakir-TasciogluSHenninkWEStormGSchiffelersRMMastrobattistaEIn vivo methods to study uptake of nanoparticles into the brainPharm Res20112845647120924653
  • HuangRQKeWLQuYHZhuJHPeiYYJiangCCharacterization of lactoferrin receptor in brain endothelial capillary cells and mouse brainJ Biomed Sci200714112112817048089
  • HuangRQKeWLLiuYJiangCPeiYYThe use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brainBiomaterials20082923824617935779